一年一度的世界肺癌大会(WCLC)又来了!本次,中国药企仍然是带着满满的研究成果前往参会。康方生物的AK112和AK104都将展现惊艳的研究成果,复宏汉霖携带PD-L1 ADC为肺癌患者带来新的治疗方案,正大天晴的双表位ADC同样值得期待。这些中国研发的管线,为肺癌治疗带来了中国方案,为全球医药界做出了中国贡献。01康方生物——全球瞩目的焦点康方生物的AK112治疗NSCLC可以说是全球瞩目的焦点...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.